These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28229425)

  • 61. Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction.
    Tokunaga M; Liu ML; Nagai T; Iwanaga K; Matsuura K; Takahashi T; Kanda M; Kondo N; Wang P; Naito AT; Komuro I
    J Mol Cell Cardiol; 2010 Dec; 49(6):972-83. PubMed ID: 20869968
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy.
    Wang F; Guan J
    Adv Drug Deliv Rev; 2010 Jun; 62(7-8):784-97. PubMed ID: 20214939
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.
    Tang J; Wang J; Kong X; Yang J; Guo L; Zheng F; Zhang L; Huang Y; Wan Y
    Exp Cell Res; 2009 Dec; 315(20):3521-31. PubMed ID: 19800880
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Application of c-kit+ Cardiac Stem Cells in Cardiac Regeneration and Repair].
    Yang M; Zhang L
    Sheng Li Ke Xue Jin Zhan; 2016 Apr; 47(2):81-7. PubMed ID: 29671980
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-inflammatory peptides from cardiac progenitors ameliorate dysfunction after myocardial infarction.
    Liu ML; Nagai T; Tokunaga M; Iwanaga K; Matsuura K; Takahashi T; Kanda M; Kondo N; Naito AT; Komuro I; Kobayashi Y
    J Am Heart Assoc; 2014 Dec; 3(6):e001101. PubMed ID: 25468657
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mechanisms of stem cell effects: insights from MRI.
    Rokosh G; Ghafghazi S; Bolli R
    Minerva Cardioangiol; 2013 Dec; 61(6):605-16. PubMed ID: 24253454
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions.
    Yan W; Xia Y; Zhao H; Xu X; Ma X; Tao L
    J Mol Cell Cardiol; 2024 Mar; 188():1-14. PubMed ID: 38246086
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Progress of Stem Cell Transplantation for Treating Myocardial Infarction.
    Chen Z; Zeng C; Wang WE
    Curr Stem Cell Res Ther; 2017; 12(8):624-636. PubMed ID: 28969536
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic effects of CXCR4
    Xu J; Wu H; Mai Z; Yi J; Wang X; Li L; Huang Z
    Cell Prolif; 2021 Jun; 54(6):e13041. PubMed ID: 33942933
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Folic Acid Derived Hydrogel Enhances the Survival and Promotes Therapeutic Efficacy of iPS Cells for Acute Myocardial Infarction.
    Li H; Gao J; Shang Y; Hua Y; Ye M; Yang Z; Ou C; Chen M
    ACS Appl Mater Interfaces; 2018 Jul; 10(29):24459-24468. PubMed ID: 29974744
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exosomes in Myocardial Repair: Advances and Challenges in the Development of Next-Generation Therapeutics.
    Adamiak M; Sahoo S
    Mol Ther; 2018 Jul; 26(7):1635-1643. PubMed ID: 29807783
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human cardiospheres are a source of stem cells with cardiomyogenic potential.
    Davis DR; Ruckdeschel Smith R; Marbán E
    Stem Cells; 2010 May; 28(5):903-4. PubMed ID: 20309960
    [No Abstract]   [Full Text] [Related]  

  • 73. Biomaterials for Stem Cell Therapy for Cardiac Disease.
    Kim H; Kim SL; Choi YH; Ahn YH; Hwang NS
    Adv Exp Med Biol; 2018; 1064():181-193. PubMed ID: 30471033
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stem cell regenerative potential combined with nanotechnology and tissue engineering for myocardial regeneration.
    Calin M; Stan D; Simion V
    Curr Stem Cell Res Ther; 2013 Jul; 8(4):292-303. PubMed ID: 23547964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mitochondrial Assays Using Cardiac Stem Cells.
    Rosdah AA; Delbridge LMD; Lim SY
    Methods Mol Biol; 2019; 2029():175-183. PubMed ID: 31273742
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cardiomyocyte Induction and Regeneration for Myocardial Infarction Treatment: Cell Sources and Administration Strategies.
    He L; Chen X
    Adv Healthc Mater; 2020 Nov; 9(22):e2001175. PubMed ID: 33000909
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interleukin-6 Mediates Post-Infarct Repair by Cardiac Explant-Derived Stem Cells.
    Mayfield AE; Kanda P; Nantsios A; Parent S; Mount S; Dixit S; Ye B; Seymour R; Stewart DJ; Davis DR
    Theranostics; 2017; 7(19):4850-4861. PubMed ID: 29187908
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Role of Neuregulin and Stem Cells as Therapy Post-Myocardial Infarction.
    Cacciapuoti M; Johnson B; Kapdia A; Powell S; Gallicano GI
    Stem Cells Dev; 2020 Oct; 29(19):1266-1274. PubMed ID: 32731805
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sustained co-delivery of BIO and IGF-1 by a novel hybrid hydrogel system to stimulate endogenous cardiac repair in myocardial infarcted rat hearts.
    Fang R; Qiao S; Liu Y; Meng Q; Chen X; Song B; Hou X; Tian W
    Int J Nanomedicine; 2015; 10():4691-703. PubMed ID: 26251592
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Concise Review: Optimized Strategies for Stem Cell-Based Therapy in Myocardial Repair: Clinical Translatability and Potential Limitation.
    Wu R; Hu X; Wang J
    Stem Cells; 2018 Apr; 36(4):482-500. PubMed ID: 29330880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.